Literature DB >> 2356852

Analysis of induced sputum in the diagnosis of Pneumocystis carinii pneumonia.

C M Kirsch1, R L Azzi, G G Yenokida, W A Jensen.   

Abstract

Sixty-two patients with possible AIDS-associated Pneumocystis carinii pneumonia (PCP) were studied to determine the diagnostic usefulness of sputum analysis and whether or not the results of sputum analysis are related to severity of disease. Induced sputum was stained with Gomori Methenamine silver and modified Wright Giemsa stains. Indicators of disease severity were: extent of chest roentgenographic infiltrate, serum lactic dehydrogenase activity, alveolar-arterial oxygen tension difference, and total blood lymphocyte count. All patients with sputum negative for Pneumocystis underwent bronchoscopy with bronchoalveolar lavage. Sputum analysis was 71% sensitive and 100% specific for the diagnosis of PCP. The negative predictive value of sputum analysis was 48%. There was no relationship between sputum results and the severity of PCP. This study led to the conclusions that sputum analysis is a sensitive, specific, rapid, and low-cost technique for the diagnosis of PCP, and that the sensitivity of sputum analysis for the detection of PCP is not affected by the severity of PCP.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2356852     DOI: 10.1097/00000441-199006000-00006

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  3 in total

Review 1.  Pneumocystis carinii pneumonia after 40 years.

Authors:  M Nouza
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

2.  Use of induced sputum specimens for microbiologic diagnosis of infections due to organisms other than Pneumocystis carinii.

Authors:  J A Fishman; R S Roth; E Zanzot; E J Enos; M J Ferraro
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

3.  Cost-effectiveness analysis of diagnostic options for pneumocystis pneumonia (PCP).

Authors:  Julie R Harris; Barbara J Marston; Nalinee Sangrujee; Desiree DuPlessis; Benjamin Park
Journal:  PLoS One       Date:  2011-08-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.